Drugs associated with bullous pemphigoid: role of HMG-COa reductase inhibitors

被引:4
|
作者
Papadopoulou, A. [1 ]
Zafiriou, E. [1 ]
Koukoulis, G. K. [2 ]
Roussaki-Schulze, A. V. [1 ]
机构
[1] Univ Thessaly, Sch Hlth Sci, Dept Dermatol, Fac Med, Larisa, Greece
[2] Univ Thessaly, Sch Hlth Sci, Dept Pathol, Fac Med, Larisa, Greece
关键词
D O I
10.1111/jdv.16243
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E269 / E270
页数:2
相关论文
共 50 条
  • [41] HMG-CoA reductase inhibitors in the prevention of stroke
    van Mil, AHM
    Westendorp, RGJ
    Bollen, ELEM
    Lagaay, AM
    Blauw, GJ
    DRUGS, 2000, 59 (01) : 1 - 6
  • [42] HMG-CoA Reductase Inhibitors in the Prevention of Stroke
    Annette H. M. van Mil
    Rudi G. J. Westendorp
    Edward L. E. M. Bollen
    A. Margot Lagaay
    Gerard J. Blauw
    Drugs, 2000, 59 : 1 - 6
  • [43] Comparison of HMG-CoA reductase inhibitors - Comment
    Shaughnessy, AF
    Slawson, DC
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (12) : 1304 - 1304
  • [44] Comparative tolerability of the HMG-CoA reductase inhibitors
    Farmer, JA
    Torre-Amione, G
    DRUG SAFETY, 2000, 23 (03) : 197 - 213
  • [45] Immunomodulatory effects of HMG-CoA reductase inhibitors
    Danesh, FR
    Anel, RL
    Zeng, LX
    Lomasney, J
    Sahai, A
    Kanwar, YS
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2003, 51 (03) : 139 - 148
  • [46] PHARMACOLOGY OF COMPETITIVE INHIBITORS OF HMG-COA REDUCTASE
    CORSINI, A
    MAGGI, FM
    CATAPANO, AL
    PHARMACOLOGICAL RESEARCH, 1995, 31 (01) : 9 - 27
  • [47] HMG-CoA REDUCTASE INHIBITORS, ANGIOGENESIS AND CANCER
    Martinez Gonzalez, J.
    Badimon, L.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2005, 17 : 31 - 39
  • [48] HMG-CoA Reductase Inhibitors and Asthma Severity
    Christiansen, S. C.
    Schatz, M.
    Eddleston, J.
    Wagelie-Steffen, A.
    Yang, S. J.
    Chen, W.
    Zuraw, B. L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S84 - S84
  • [50] HMG-CoA reductase inhibitors for the prevention of nephropathy
    Maisch, NM
    Pezzillo, KK
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (02) : 342 - 345